Last updated on June 2019

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma


Brief description of study

The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE (Etoposide, Idarubicin, Trofosfamide) for 6 months improves the event free survival (EFS) in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma.

Clinical Study Identifier: NCT00876031

Find a site near you

Start Over

Landeskrankenhaus

Klagenfurt, Austria
  Connect »

Charit

Berlin, Germany
  Connect »

Klinikum Braunschweig

Braunschweig, Germany
  Connect »

Asklepios Kinderklinik

Sankt Augustin, Germany
  Connect »

Olgahospital

Stuttgart, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.